TELA Bio, Inc. stock is down -2.92% since 30 days ago. The next earnings date is Mar 19, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 4 December’s closed higher than November. 100% of analysts rate it a buy.
TELA Bio, Inc. focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company markets its products through a single direct sales force, principally in the United States.